← Back
$VNDA All transactions

Vanda Pharmaceuticals Inc.

▼ SELL

$ Value

$1.3M

Shares

156,235

Price

$8

Filed

Mar 4

Insider

Name

Polymeropoulos Mihael Hristos

Title

President and CEO

CIK

0001355537

Roles

Director Officer Other

Transaction Details

Transaction Date

2026-03-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,704,496

Footnotes

Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to the withholding tax provisions of the RSU agreements. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.08 to $8.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Filing Info

Accession No.

0001355537-26-000002

Form Type

4

Issuer CIK

0001347178

Polymeropoulos Mihael Hristos's History

Date Ticker Type Value
2026-03-02 VNDA $1.3M
2026-02-18 VNDA A $0
2025-08-07 VNDA $42K
2025-05-21 VNDA $42K
2025-05-21 VNDA $2K
2025-05-16 VNDA $84K

Other Insiders at VNDA (90d)

Insider Bought Sold Last
Polymeropoulos Mihael Hristos
President and CEO
2026-02-18
Birznieks Gunther
SVP, Business Development
$351K 2026-03-02
Williams Timothy
SVP & General Counsel
$351K 2026-03-02
Wijkstrom Joakim
SVP, Chief Marketing Officer
$255K 2026-03-02
Moran Kevin Patrick
SVP, CFO & Treasurer
$351K 2026-03-02
Honore Tage $241K 2026-02-23